Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT07211035
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Amplifi Vascular, Inc.
- Registry
-
NCT07211035
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07211035. Randomized; single masking; primary purpose treatment. Start 2026-05-12 (actual); primary completion 2027-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
- Acronym
- AMPLIFI-1
- Condition
- End Stage Kidney Disease (ESRD)
- Intervention (Device)
- The Amplifi System is a temporary extracorporeal blood pump designed to deliver controlled flow through a peripheral vein for 24-72 hours prior to AVF creation.
- Intervention (Procedure)
- Standard of Care (AVF creation)
- Lead sponsor
- Amplifi Vascular, Inc.
Record details
- Record id
cardio:ct-nct07211035- Content hash
a35820fcecca3602eaf09bfb8a897371b148089efcb9f55a64743ddedfa507e9